Edinoff, A.N.; Thompson, E.; Merriman, C.E.; Alvarez, M.R.; Alpaugh, E.S.; Cornett, E.M.; Murnane, K.S.; Kozinn, R.L.; Shah-Bruce, M.; Kaye, A.M.;
et al. Oxytocin, a Novel Treatment for Methamphetamine Use Disorder. Neurol. Int. 2022, 14, 186-198.
https://doi.org/10.3390/neurolint14010015
AMA Style
Edinoff AN, Thompson E, Merriman CE, Alvarez MR, Alpaugh ES, Cornett EM, Murnane KS, Kozinn RL, Shah-Bruce M, Kaye AM,
et al. Oxytocin, a Novel Treatment for Methamphetamine Use Disorder. Neurology International. 2022; 14(1):186-198.
https://doi.org/10.3390/neurolint14010015
Chicago/Turabian Style
Edinoff, Amber N., Elliot Thompson, Chandler E. Merriman, Mark R. Alvarez, E. Saunders Alpaugh, Elyse M. Cornett, Kevin S. Murnane, Rachel L. Kozinn, Mila Shah-Bruce, Adam M. Kaye,
and et al. 2022. "Oxytocin, a Novel Treatment for Methamphetamine Use Disorder" Neurology International 14, no. 1: 186-198.
https://doi.org/10.3390/neurolint14010015
APA Style
Edinoff, A. N., Thompson, E., Merriman, C. E., Alvarez, M. R., Alpaugh, E. S., Cornett, E. M., Murnane, K. S., Kozinn, R. L., Shah-Bruce, M., Kaye, A. M., & Kaye, A. D.
(2022). Oxytocin, a Novel Treatment for Methamphetamine Use Disorder. Neurology International, 14(1), 186-198.
https://doi.org/10.3390/neurolint14010015
